|Event Name||2017 PDA Annual Meeting
Monday, April 03, 2017
Wednesday, April 05, 2017
|Description||PDA’s flagship Annual Meeting provides a venue for obtaining the latest and most comprehensive information on a broad range of topics related to processing, manufacturing and quality control. More importantly, the Annual Meeting is the ideal forum for sharing best practices and learning how industry is applying novel approaches for development and commercialization of pharmaceutical and biopharmaceutical products. The trend continues with the 2017 PDA Annual Meeting taking place April 3-5 in Anaheim, CA.
The theme of the 2017 meeting is Manufacturing Innovation: The Next Wave of Sterile & Biopharmaceutical Science, Technologies & Processing. In selecting this theme, the goal was to design an inclusive event that encompasses the wide ranging interests of all PDA members. Relevant information important to both small molecule pharmaceutical and biopharmaceutical industries will be covered. Taking full advantage of the meeting being held in the United States, which is known as being a “hot bed” of innovation, novel approaches and future strategies for bringing products to the market will figure prominently on the program.
Plenary sessions focus on advanced therapeutic strategies, including the emerging fields of immunotherapy, gene and cell-based therapies. Emphasis is placed on science and technologies needed to bring these innovative products to the patient. Additional plenary sessions further explore current and future trends in process development and manufacturing, including topics on next generation processing and facilities, application of big data for process design and optimization and accelerating the industry response to healthcare needs. Concurrent sessions were designed to support the Conference theme and allow meeting participants to take a deeper look at the technology, science and processing approaches that are shaping our industry now and in the future. These focus areas form the basis of tracks that include topics related to advances in analytical sciences and quality control strategies, developments in patient-centered precision medicine and next generation manufacturing.
Rounding out the program are Breakfast sessions and Interest Group meetings offering the opportunity for meeting participants to engage in interactive discussions on a wide range of important topics and specific disciplines. The exhibition hall will offer opportunities for one-on-one interactions with service providers and vendors showcasing the latest services and technologies. Authors of numerous poster presentations will also be present to discuss their latest research and data. Social events and breaks are scheduled throughout the meeting to allow time for further networking and peer-to-peer discussions.
Don’t miss out on this important learning opportunity. Make plans now to attend the 2017 PDA Annual Meeting.
At the completion of this event, attendees will be able to:
• Determine manufacturing and quality requirements for immunotherapies, gene and cell therapy products
• Describe continuous manufacturing applications and flexible facility designs of the future
• Demonstrate how big data can be applied to design and optimize manufacturing processes
• Define strategies to accelerate new products to the market
• Interpret the latest trends in microbiological and adventitious agent control strategies
• Identify advanced analytical approaches that can be applied for quality control and real time release
• Explain delivery system design and manufacturing logistics for patient-centered therapies and precision medicine
• Summarize best practices for identifying and introducing new technologies
Who Should Attend
Scientist | Executive and Mid-Level Management | Project Management | Technical Services | Supply Chain | Manufacturing Application | Risk Management
Manufacturing | Product Development | Quality | Research & Development | Regulatory Affairs | Engineering | Laboratory Science | Information Technology | Validation | Training
|Host Company||Parenteral Drug Association
+1-301-656-5900 ext. 111